# Early phase 1 sclerosis trials recruiting: 20 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 20 trials in early phase 1 for sclerosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Early phase 1 sclerosis trials: 20 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/early-phase-1/sclerosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 20
- Recruiting or not yet: 20
- Read on: November 19, 2026

## Trials

The 20 newest of 20, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| August 6, 2026 | NCT07748637 | A Clinical Study to Evaluate the Safety and Efficacy of GT802 Injection in the Treatment of Relapsing/Refractory Multiple Sclerosis | Sponsor not shown (see the record) | Early phase 1 | Not yet recruiting | Multiple Sclerosis (MS) | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07748637) |
| June 12, 2026 | NCT07643974 | Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD | Medstar Health Research Institute | Early phase 1 | Not yet recruiting | Spinal Cord Injury, Neurogenic Bladder (NB), Neurogenic Lower Urinary Tract Dysfunction, Multiple Sclerosis, Spina... | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07643974) |
| April 22, 2026 | NCT07546110 | An Open-Label, Single-Arm Clinical Study to Evaluate the Safety and Preliminary Efficacy of CD20 Monoclonal Antibody Combined With NK042... | The Affiliated Hospital of Xuzhou Medical University | Early phase 1 | Not yet recruiting | Multiple Sclerosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07546110) |
| February 6, 2026 | NCT07392528 | Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/ BCMA（QT-019C） in Patients With r/ r Neurological... | Tianjin Huanhu Hospital | Early phase 1 | Not yet recruiting | Neuromyelitis Optica Spectrum Disorders, Multiple Sclerosis, Myasthenia Gravis | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07392528) |
| January 13, 2026 | NCT07337785 | CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases | Tongji Hospital | Early phase 1 | Recruiting | Relapsing or Refractory Multiple Sclerosis (MS), Myasthenia Gravis (MG), Chronic Inflammatory Demyelinating... | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07337785) |
| December 26, 2025 | NCT07303790 | This is an Early Exploratory Study to Assess the Tolerability and Safety of GC012F in Patients With Multiple Sclerosis | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Multiple Sclerosis | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07303790) |
| November 4, 2025 | NCT07224269 | Effect of Terazosin on ATP Levels in People With Amyotrophic Lateral Sclerosis | University of Iowa | Early phase 1 | Recruiting | Amyotrophic Lateral Sclerosis, Adenosine Triphosphate Activities | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07224269) |
| July 23, 2025 | NCT07080801 | Study on the Safety and Efficacy of RAG-21 in the Treatment of Amyotrophic Lateral Sclerosis Patients With FUS Gene Mutations | Beijing Tiantan Hospital | Early phase 1 | Not yet recruiting | Amyotrophic Lateral Sclerosis (ALS) | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07080801) |
| July 22, 2025 | NCT07077668 | Extended Study of RAG-17 in the Treatment of Amyotrophic Lateral Sclerosis Patients With SOD1 Gene Mutation | Beijing Tiantan Hospital | Early phase 1 | Not yet recruiting | ALS (Amyotrophic Lateral Sclerosis) | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07077668) |
| April 22, 2025 | NCT06939166 | Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r... | Tianjin Huanhu Hospital | Early phase 1 | Recruiting | Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Multiple Sclerosis, Chronic Inflammatory Demyelinating... | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06939166) |
| March 24, 2025 | NCT06891716 | \[18F\]ACI-19626 PET in TDP-43 Proteinopathies | AC Immune SA | Early phase 1 | Recruiting | Frontotemporal Dementia (FTD), Amyotrophic Lateral Sclerosis (ALS), TDP-43 Proteinopathies, Suspected Limbic... | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06891716) |
| February 27, 2025 | NCT06849609 | A Study to Evaluate the Tolerability, Safety and Efficacy of VGN-R13 in Patients with ALS | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Amyotrophic Lateral Sclerosis (ALS) | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06849609) |
| February 11, 2025 | NCT06819358 | Individualized Functional Imaging-Guided Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Postural Gait Disorders in... | Peking University Third Hospital | Early phase 1 | Not yet recruiting | Amyotrophic Lateral Sclerosis (ALS) | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06819358) |
| November 15, 2024 | NCT06689982 | Tofacitinib in Patients With Amyotrophic Lateral Sclerosis | Beijing Tiantan Hospital | Early phase 1 | Not yet recruiting | Amyotrophic Lateral Sclerosis | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06689982) |
| October 24, 2024 | NCT06656702 | Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis | Johns Hopkins University | Early phase 1 | Recruiting | Amyotrophic Lateral Sclerosis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06656702) |
| October 16, 2024 | NCT06645197 | An IIT Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of a Single Intrathecal Injection of SNUG01 in... | Peking University Third Hospital | Early phase 1 | Not yet recruiting | Amyotrophic Lateral Sclerosis (ALS) | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06645197) |
| July 3, 2024 | NCT06485232 | Universal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System. | Xuanwu Hospital, Beijing | Early phase 1 | Not yet recruiting | Neuromyelitis Optica Spectrum Disorders, Myasthenia Gravis, Generalized, Multiple Sclerosis, Chronic Inflammatory... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06485232) |
| November 18, 2020 | NCT04634994 | Assessment of Synaptic Density in MS | Brigham and Women's Hospital | Early phase 1 | Recruiting | Multiple Sclerosis | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04634994) |
| September 23, 2020 | NCT04561557 | Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System | Tongji Hospital | Early phase 1 | Recruiting | Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder, Myasthenia... | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04561557) |
| May 15, 2020 | NCT04390009 | Entire-body PET Scans for Multiple Sclerosis | Brain Health Alliance | Early phase 1 | Recruiting | Multiple Sclerosis | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04390009) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Beijing Tiantan Hospital | 3 |
| Tianjin Huanhu Hospital | 2 |
| Peking University Third Hospital | 2 |
| Tongji Hospital | 2 |
| The Affiliated Hospital of Xuzhou Medical University | 1 |
| Xuanwu Hospital, Beijing | 1 |
| Medstar Health Research Institute | 1 |
| Brain Health Alliance | 1 |
| Brigham and Women's Hospital | 1 |
| Johns Hopkins University | 1 |
| University of Iowa | 1 |
| AC Immune SA | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 10 |
| United States | 5 |
| Netherlands | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Surgical supply companies in the United States](https://specstream.ai/data/businesses/surgical-supply-companies/united-states)
- [Doctors' offices in the United States](https://specstream.ai/data/businesses/doctors-offices/united-states)
- [Pediatric surgery practices in the United States](https://specstream.ai/data/businesses/pediatric-surgery-practices/united-states)
- [Bankruptcy law firms in the United States](https://specstream.ai/data/businesses/bankruptcy-law-firms/united-states)
- [Israeli restaurants in the United States](https://specstream.ai/data/businesses/israeli-restaurants/united-states)
- [Ultrasound imaging clinics in the United States](https://specstream.ai/data/businesses/ultrasound-imaging-clinics/united-states)
